You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
內地啓動第十一批國家組織藥品集採報量
國家醫保局表示,國家組織藥品聯合採購辦公室近日公佈,自昨日(6日)至本月25日開展第十一批藥品集採醫療機構需求量填報工作。
此次集採共涉及55個品種,報量工作涉及醫療機構可按廠牌報量,將集採優化報量規則,醫療機構可不區分廠牌、按通用名填報每個品種的需求量,也可以細化到具體廠牌,引導醫療機構認可度高的企業積極參與。
此次集採原則上要求每家醫療機構每個品種的年需求量不低於2023年至2024年度平均使用量的80%。同時,對於存在臨牀需求明顯減少及業務調整等因素導致預期用量顯着減少的,醫療機構可作出書面說明後按實際需求報量。
此外,對於基本藥物規格,報量系統中專門作出標註,如該規格未通過質量和療效一致性評價,醫療機構可自行確定折算比例,並在報量時作出說明。對於兒童適宜品規,如未通過一致性評價,醫療機構認爲難以替代及報量無法折算的,可根據實際需要報量並作出說明。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.